Case ReportsEslicarbazepine Acetate in the Management of Refractory Bipolar DisorderNath, Kamal MBBS, MD*; Bhattacharya, Arnab MBBS, DPM†; Praharaj, Samir Kumar MBBS, MD, DPM‡Author Information *Department of Psychiatry, Silchar Medical College and Hospital, Silchar, Assam; †Tata Motors Hospital, Jamshedpur, India; and ‡Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka, India. Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare. Address correspondence and reprint requests to Samir Kumar Praharaj, MBBS, MD, DPM, Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka, India 576104; E-mail: email@example.com Clinical Neuropharmacology: November/December 2012 - Volume 35 - Issue 6 - p 295 doi: 10.1097/WNF.0b013e318271220b Buy Metrics Abstract Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect. © 2012 Lippincott Williams & Wilkins, Inc.